We've found
3,657 Endocrine
clinical trials
We've found
3,657 Endocrine
clinical trials
Endocrinology, Oncology Clinical Trial
Updated: 3/13/2012
Atorvastatin Calcium in Preventing Metabolic Syndrome in Patients With Prostate Cancer Receiving Long-Term Androgen-Deprivation Therapy
Status: Enrolling
Updated: 3/13/2012
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Impaired Glucose Tolerance Clinical Trial
Updated: 8/11/2008
Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance
Status: Enrolling,
Phase
IV
Updated: 8/11/2008
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Hypoparathyroidism Clinical Trial
Updated: 12/31/1969
A Registry for Patients With Chronic Hypoparathyroidism
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Hypoparathyroidism Clinical Trial
Updated: 12/31/1969
A Registry for Patients With Chronic Hypoparathyroidism
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Hypoparathyroidism Clinical Trial
Updated: 12/31/1969
A Registry for Patients With Chronic Hypoparathyroidism
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Hypoparathyroidism Clinical Trial
Updated: 12/31/1969
A Registry for Patients With Chronic Hypoparathyroidism
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Hypoparathyroidism Clinical Trial
Updated: 12/31/1969
A Registry for Patients With Chronic Hypoparathyroidism
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Hypoparathyroidism Clinical Trial
Updated: 12/31/1969
A Registry for Patients With Chronic Hypoparathyroidism
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Hypoparathyroidism Clinical Trial
Updated: 12/31/1969
A Registry for Patients With Chronic Hypoparathyroidism
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Hypoparathyroidism Clinical Trial
Updated: 12/31/1969
A Registry for Patients With Chronic Hypoparathyroidism
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Hypoparathyroidism Clinical Trial
Updated: 12/31/1969
A Registry for Patients With Chronic Hypoparathyroidism
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Acromegaly Clinical Trial
Updated: 12/26/2015
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling,
Phase
IV
Updated: 12/26/2015
Click here to add this to my saved trials

Acromegaly Clinical Trial
Updated: 12/26/2015
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling,
Phase
IV
Updated: 12/26/2015
Click here to add this to my saved trials

Acromegaly Clinical Trial
Updated: 12/26/2015
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling,
Phase
IV
Updated: 12/26/2015
Click here to add this to my saved trials

Acromegaly Clinical Trial
Updated: 12/26/2015
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling,
Phase
IV
Updated: 12/26/2015
Click here to add this to my saved trials

Acromegaly Clinical Trial
Updated: 12/26/2015
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling,
Phase
IV
Updated: 12/26/2015
Click here to add this to my saved trials

Acromegaly Clinical Trial
Updated: 12/26/2015
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling,
Phase
IV
Updated: 12/26/2015
Click here to add this to my saved trials

Acromegaly Clinical Trial
Updated: 12/26/2015
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling,
Phase
IV
Updated: 12/26/2015
Click here to add this to my saved trials

Acromegaly Clinical Trial
Updated: 12/26/2015
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling,
Phase
IV
Updated: 12/26/2015
Click here to add this to my saved trials

Acromegaly Clinical Trial
Updated: 12/26/2015
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling,
Phase
IV
Updated: 12/26/2015
Click here to add this to my saved trials

Acromegaly Clinical Trial
Updated: 12/26/2015
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling,
Phase
IV
Updated: 12/26/2015
Click here to add this to my saved trials

Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 4/16/2014
Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.
Status: Enrolling,
Phase
I, II
Updated: 4/16/2014
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Metabolic Syndrome Clinical Trial
Updated: 12/31/1969
Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Microalbuminuria in Type Two Diabetes Clinical Trial
Updated: 1/28/2014
Use of Sitagliptin to Decrease Microalbuminuria
Status: Enrolling,
Phase
IV
Updated: 1/28/2014
Click here to add this to my saved trials

Insulin Resistance Clinical Trial
Updated: 12/2/2015
Pilot Study to Test Dietary Fat Delivery
Status: Enrolling
Updated: 12/2/2015
Click here to add this to my saved trials

Endocrinology, Neurology Clinical Trial
Updated: 12/31/1969
Improving Autonomic Function and Balance in Diabetic Neuropathy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Major Depressive Disorder Clinical Trial
Updated: 12/31/1969
Cognitive Behavior Therapy for Depression Depression
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Nephrology / Urology, Neurology, Oncology, Ophthalmology, Pharmacology / Toxicology, Psychiatry / Psychology, Rheumatology, Orthopedics / Podiatry, Other, Reproductive Clinical Trial
Updated: 12/31/1969
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Thyroid Eye Disease Clinical Trial
Updated: 12/2/2014
Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease
Status: Enrolling,
Phase
IV
Updated: 12/2/2014
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 1/24/2018
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Status: Enrolling,
Phase
II
Updated: 1/24/2018
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 1/24/2018
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Status: Enrolling,
Phase
II
Updated: 1/24/2018
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 1/24/2018
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Status: Enrolling,
Phase
II
Updated: 1/24/2018
Click here to add this to my saved trials

Insulin Resistance Clinical Trial
Updated: 12/22/2014
Effect of Vitamin D Supplementation on Oral Glucose Tolerance Among Obese Adolescents
Status: Enrolling
Updated: 12/22/2014
Click here to add this to my saved trials

Bipolar Youth Treated With Second-generation Antipsychotics Clinical Trial
Updated: 8/21/2015
SGA-induced Metabolic Syndrome in Bipolar Youth
Status: Enrolling,
Phase
III
Updated: 8/21/2015
Click here to add this to my saved trials

Endocrinology, Nephrology / Urology Clinical Trial
Updated: 5/21/2013
Detection of Celiac Disease in Patients With Hypothyroidism
Status: Enrolling
Updated: 5/21/2013
Click here to add this to my saved trials

Click here to add this to my saved trials

Polycystic Ovary Syndrome (PCOS) Clinical Trial
Updated: 12/31/1969
Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/4/2015
Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS)
Status: Enrolling,
Phase
IV
Updated: 12/4/2015
Click here to add this to my saved trials

Endocrinology, Hematology, Neurology, Pharmacology / Toxicology, Rheumatology, Other Clinical Trial
Updated: 12/31/1969
MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Reproductive Clinical Trial
Updated: 4/11/2018
Assessment of Day-night Secretion of Progesterone and LH Across Puberty
Status: Enrolling,
Phase
Updated: 4/11/2018
Click here to add this to my saved trials

Endocrine Disorders Clinical Trial
Updated: 6/12/2014
Salivary Cortisol Measurements by Mass Spectrometry
Status: Enrolling
Updated: 6/12/2014
Click here to add this to my saved trials

Cushings Disease Clinical Trial
Updated: 12/31/1969
Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
The Effect of Artificial Sweeteners (AFS) on Sweetness Sensitivity, Preference and Brain Response in Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Glycogen Storage Disease Clinical Trial
Updated: 1/21/2016
Clinical Evaluation of a Non-Invasive Hypoglycemia Detector in a Glycogen Storage Disease Population
Status: Enrolling
Updated: 1/21/2016
Click here to add this to my saved trials

Endocrinology, Neurology, Orthopedics / Podiatry, Other Clinical Trial
Updated: 12/31/1969
Testosterone Plus Finasteride Treatment After Spinal Cord Injury
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 12/31/1969
Apixaban for the Secondary Prevention of Thromboembolism Among Patients With the AntiphosPholipid Syndrome
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
Diet and Exercise in Pompe Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Metabolic Syndrome Clinical Trial
Updated: 3/20/2018
Resveratrol in Metabolic Syndrome: Effect on Platelet Hyper-reactivity and HDL Lipid Peroxidation
Status: Enrolling,
Phase
III
Updated: 3/20/2018
Click here to add this to my saved trials

Refractory Hurthle Cell Thyroid Cancer Clinical Trial
Updated: 12/31/1969
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Hypogonadism Clinical Trial
Updated: 9/10/2014
Oral Testosterone for the Treatment of Hypogonadism in Males
Status: Enrolling,
Phase
II
Updated: 9/10/2014
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
A Phase II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Neurology, Pharmacology / Toxicology, Other Clinical Trial
Updated: 12/31/1969
UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Prediabetes Clinical Trial
Updated: 3/15/2016
Almond Effects on Glucose Intolerance Study
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials

Endocrinology, Oncology, Other Clinical Trial
Updated: 10/9/2015
Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid
Status: Enrolling,
Phase
I
Updated: 10/9/2015
Click here to add this to my saved trials

Endocrinology, Oncology, Other Clinical Trial
Updated: 10/9/2015
Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid
Status: Enrolling,
Phase
I
Updated: 10/9/2015
Click here to add this to my saved trials

Differentiated Thyroid Cancer Clinical Trial
Updated: 12/31/1969
Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Neurology Clinical Trial
Updated: 12/31/1969
Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
